Shaily Engineering Plastics Ltd
Shaily Engineering Plastics Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Healthcare segment revenue grew 139% in FY26 to INR393 crores, driven by pen injector ramp-up and GLP-1 product launches in India, Canada, and upcoming other countries. FY26 marked by smooth execution and improved operational performance; confident of profitable, sustainable growth in coming years (Amit Sanghvi, closing remarks).
From Shaily Engineering Plastics Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Healthcare segment revenue grew 139% in FY26 to INR393 crores, driven by pen injector ramp-up and GLP-1 product launches in India, Canada, and upcoming other countries.
- Pen injector order of INR423 crores is spread over 4 years, with regular supplies expected to ramp up.
- Total pen injector capacity expected to reach 80 million pens by July-August FY27, targeting 36 million pens supply in FY27 and around 50 million pens in FY28.
- Full utilization of pen injector capacity anticipated within next 2-3 years, with healthcare segment expected to sustain strong growth.
- Consumer segment declined 9% in FY26 but expected to recover as global demand improves; new products being added to consumer space.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Shaily Engineering Plastics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is evaluating setting up a new plant for consumer electronics, with an initial estimated capex of around INR 100 crores.
- Additional substantial capex is expected for scaling new device capacities, including healthcare-related projects that cannot be serviced from existing sites like India or Abu Dhabi.
- A capital raising resolution is in place as an enablement option for time-sensitive, capital-intensive projects, though no immediate capital is being raised.
- There is ongoing investment in the new pen injector production lines, with capacity being added (25 million pens added in March, another 25 million expected by July-August).
2 more points management made on capital expenditure plans
Top-ranked in Consumer Durables
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Shaily Engineering Plastics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company has a recently announced INR 423 crore pen injector order spread over 4 years (Q4 FY26 transcript).
- The order is incremental and for pen injector supplies over 4 years.
- For FY27, guidance is around 36 million pens for pen injector supplies.
- Existing capacity for pen injectors is 30 million pens; an additional 25 million was added in March and another 25 million expected by July/August, totaling 80 million pens capacity.
- The healthcare revenue ramp-up is expected with new product launches in India, Canada, and upcoming launches in other countries.
- The consumer segment saw a decline and is expected to recover as global demand improves.
2 more points management made on order book & pipeline
Shaily Engineering Plastics Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹224 Cr, net profit ₹49 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Shaily Engineer.'s management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q2 FY26 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Consumer Durables this season
- Hardwyn India Ltd (Q4 FY26)
Q4FY26 Operating Revenue: ₹5715.13 Lakhs vs ₹4564.19 Lakhs in Q4FY25, a 25.22% YoY increase (Page 16). Key concall takeaways from Hardwyn India Ltd's Q4 FY26…
- V I P Industries Ltd (Q4 FY26)
Offline + Caprese revenue in H1 FY26: Rs 750 Cr (–11% YoY); H2 FY26: Rs 724 Cr (–3% YoY) . Key concall takeaways from V I P Industries Ltd's Q4 FY26 earnings…
- Tribhovandas Bhimji Zaveri Ltd (Q4 FY26)
Q4 FY26 revenue from operations: ₹8,296.95 million, up 56.74% YoY (Page 9, 8) . Key concall takeaways from Tribhovandas Bhimji Zaveri Ltd's Q4 FY26 earnings…
- Bai-Kakaji Polymers Ltd (Q4 FY26)
Q4/FY26 Revenue from Operations: ₹364.69 Crore vs ₹325.37 Crore in FY25, a +12.1% year-on-year increase (Page 5). Key concall takeaways from Bai-Kakaji…
Frequently Asked Questions
What were Shaily Engineering Plastics Ltd Q4 FY26 results?
Healthcare segment revenue grew 139% in FY26 to INR393 crores, driven by pen injector ramp-up and GLP-1 product launches in India, Canada, and upcoming other countries. FY26 marked by smooth execution and improved operational performance; confident of profitable, sustainable growth in coming years (Amit Sanghvi, closing remarks).
What is Shaily Engineering Plastics Ltd share price analysis?
Shaily Engineering Plastics Ltd currently shows a neutral. The stock trades at a P/E of 90.6 with a market cap of ₹14,609 Cr. Investors should review the full earnings analysis for detailed insights.
Is Shaily Engineering Plastics Ltd planning capital expenditure?
The company is evaluating setting up a new plant for consumer electronics, with an initial estimated capex of around INR 100 crores.
Keep Shaily Engineering Plastics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.